Financial insights of ABBV

MyFinsight

For the quarter ending 2025-09-30, ABBV made $15,776M in revenue. $186M in net income. Net profit margin of 1.18%.

Unit: Million (M) dollars (except for numbers of shares and EPS)

Income Statement	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Net revenues	15,776	15,423	13,343	14,460
Cost of products sold	5,304	4,346	4,002	4,212
Selling, general and administrative	3,569	3,253	3,293	4,205
Research and development	2,319	2,131	2,067	2,130
Acquired ipr&d and milestones	2,680	823	248	82
Other operating income	0	24	-	0
Total operating costs and expenses	13,872	10,529	9,610	10,629
Operating earnings	1,904	4,894	3,733	3,831
Interest expense, net	-667	-678	-627	-591
Net foreign exchange loss (gain)	-20	-23	-4	3
Other expense, net	-503	-2,639	-1,441	-1,159
Earnings before income tax expense	714	1,554	1,661	2,084
Income tax expense	526	613	372	520
Net earnings	188	941	1,289	1,564
Net earnings attributable to noncontrolling interest	2	3	3	3
Net earnings attributable to abbvie inc	186	938	1,286	1,561

Basic earnings per share (in dollars per share)	0.1	0.52	0.72	0.88
Diluted earnings per share (in dollars per share)	0.1	0.52	0.72	0.88
Weighted-average basic shares outstanding (in shares)	1,769,000,000	1,768,000,000	1,768,000,000	1,769,000,000
Weighted-average diluted shares outstanding (in shares)	1,772,000,000	1,771,000,000	1,772,000,000	1,772,000,000